Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: Results of a retrospective study

Strahlentherapie und Onkologie

Volumn 187, Issue 8, 2011, Pages 467-472

  Siegmann, Alessandra ^a   Bottke, Dirk ^b   Faehndrich, Julia ^a   Lohm, Gunnar ^a   Miller, Kurt ^a   Bartkowiak, Detlef ^b   Wiegel, Thomas ^b   Hinkelbein, Wolfgang ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Dose escalation; Prostate cancer; Radical prostatectomy; Salvage radiotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INFILTRATION; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CYSTITIS; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROSTATE CANCER; PROSTATECTOMY; PROTEIN BLOOD LEVEL; RADIATION DOSE; RADIATION INJURY; RECTUM HEMORRHAGE; SALVAGE RADIOTHERAPY; SALVAGE THERAPY; SEMINAL VESICLE; TENESMUS; URETHRA STRICTURE;

AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; SALVAGE THERAPY; TUMOR MARKERS, BIOLOGICAL;

EID: 80052267238     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-2229-3     Document Type: Article

References (32)

1. M.S. Anscher R. Clough R. Dodge 2000 Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years Int J Radiat Oncol Biol Phys 48 369 375 10974449 10.1016/S0360-3016(00)00645-3 1:STN:280:DC%2BD3cvlvVCjsw%3D%3D
2. J.R. Bernard Jr. S.J. Buskirk M.G. Heckman, et al. 2010 Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysis Int J Radiat Oncol Biol Phys 76 735 740 19464818 10.1016/j.ijrobp.2009.02.049
3. M. Bohrer P. Schroder G. Welzel, et al. 2008 Reduced rectal toxicity with ultrasound-based image guided radiotherapy using BAT (B-mode acquisition and targeting system) for prostate cancer Strahlenther Onkol 184 674 678 19107349 10.1007/s00066-008-1837-z
4. M. Bolla H. van Poppel L. Collette, et al. 2005 Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) Lancet 366 572 578 16099293 10.1016/S0140-6736(05)67101-2 (Pubitemid 41140332)
5. D. Bottke T.M. de Reijke D. Bartkowiak, et al. 2009 Salvage radiotherapy in patients with persisting/rising PSA after radical prostatectomy for prostate cancer Eur J Cancer 45 Suppl1 148 157 19775613 10.1016/S0959-8049(09)70027-9
6. D. Bottke T. Wiegel 2010 Radiotherapy and Prostate Cancer: Quo Vadis? Eur Urol 9 Suppl 394 400
7. A.K. Chawla H.K. Thakral A.L. Zietman, et al. 2002 Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma: analysis of efficacy and prognostic factors Urology 59 726 731 11992848 10.1016/S0090-4295(02)01540-6 (Pubitemid 34461985)
8. F.K. Chun M. Graefen M. Zacharias, et al. 2006 Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer World J Urol 24 273 280 16506049 10.1007/s00345-006-0058-2 (Pubitemid 44138182)
9. J.J. Coen A.L. Zietman H. Thakral, et al. 2002 Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastases J Clin Oncol 20 3199 3205 12149291 10.1200/JCO.2002.01.086 (Pubitemid 34831515)
10. D.R. Cox 1972 Regression models and life tables J R Stat Soc B34 187 202
11. T. Do R.G. Parker C. Do, et al. 1998 Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy Cancer J Sci Am 4 324 330 9815297 1:STN:280:DyaK1M%2FjsFGisw%3D%3D
12. M. Guckenberger S. Ok B. Polat, et al. 2010 Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer Strahlenther Onkol 186 535 543 20890743 10.1007/s00066-010-2144-z
13. E.L. Kaplan P. Meier 1958 Nonparametric estimation from incomplete observations J Amer Stat Ass 53 457 462 10.2307/2281868
14. C.R. King M.T. Spiotto 2008 Improved outcomes with higher doses for salvage radiotherapy after prostatectomy Int J Radiat Oncol Biol Phys 71 23 27 18207668 10.1016/j.ijrobp.2007.09.047
15. O.K. Macdonald S.E. Schild S.A. Vora, et al. 2003 Radiotherapy for men with isolated increase in serum prostate specific antigen after radical prostatectomy J Urol 170 1833 1837 14532786 10.1097/01.ju.0000091835.80547.a4 (Pubitemid 37254938)
16. M.M. Morris K.C. Dallow A.L. Zietman, et al. 1997 Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer Int J Radiat Oncol Biol Phys 38 731 736 9240639 10.1016/S0360-3016(97)00080-1 1:STN:280:DyaK2szot1Kgtw%3D%3D (Pubitemid 27310541)
17. J.F. Pazona M. Han S.A. Hawkins, et al. 2005 Salvage radiation therapy for prostate specific antigen progression following radical prostatectomy: 10-year outcome estimates J Urol 174 1282 1286 16145393 10.1097/01.ju. 0000173911.82467.f9 (Pubitemid 41318704)
18. F. Pinto T. Prayer-Galetti M. Gardiman, et al. 2006 Clinical and pathological characteristics of patients presenting with biochemical progression after radical retropubic prostatectomy for pathologically organ-confined prostate cancer Urol Int 76 202 208 16601379 10.1159/000091619 1:STN:280:DC%2BD287psFOmuw%3D%3D
19. T.M. Pisansky T.F. Kozelsky R.P. Myers, et al. 2000 Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer J Urol 163 845 850 10687990 10.1016/S0022-5347(05)67817-2 1:STN:280:DC%2BD3c7ltVKqug%3D%3D (Pubitemid 30091629)
20. K.A. Roehl M. Han C.G. Ramos, et al. 2004 Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results J Urol 172 910 914 15310996 10.1097/01.ju.0000134888.22332.bb (Pubitemid 39096421)
21. M.L. Sautter-Bihl F. Sedlmayer T. Wiegel 2009 Postoperative radiotherapy for advanced prostate cancer: improved local control translates into increased survival Strahlenther Onkol 185 485 487 19652929 10.1007/s00066-009-8001-2
22. S.E. Schild S.J. Buskirk W.W. Wong, et al. 1996 The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy J Urol 156 1725 1729 8863580 10.1016/S0022-5347(01)65492-2 1:STN:280:DyaK2s%2Fhs12ltQ%3D%3D (Pubitemid 26344027)
23. B. Shekarriz J. Upadhyay D.P. Wood Jr., et al. 1999 et al. Vesicourethral anastomosis biopsy after radical prostatectomy: predictive value of prostate-specific antigen and pathologic stage Urology 54 1044 1048 10604706 10.1016/S0090-4295(99)00351-9 1:STN:280:DC%2BD3c%2FmvVajtA%3D%3D
24. V. Steil F. Schneider B. Kupper, et al. 2009 [Patient-centered image and data management in radiation oncology] Strahlenther Onkol 185 1 7 19224141 10.1007/s00066-009-1857-3
25. A.J. Stephenson P.T. Scardino M.W. Kattan, et al. 2007 Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy J Clin Oncol 25 2035 2041 17513807 10.1200/JCO.2006.08.9607 (Pubitemid 46972788)
26. A.J. Stephenson S.F. Shariat M.J. Zelefsky, et al. 2004 Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy JAMA 291 1325 1332 15026399 10.1001/jama.291.11.1325 1:CAS:528:DC%2BD2cXitlKntr0%3D (Pubitemid 38541647)
27. P. Swindle J.A. Eastham M. Ohori, et al. 2008 Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens J Urol 179 S47 S51 18405751 10.1016/j.juro.2008.03.137 (Pubitemid 351483915)
28. I.M. Thompson C.M. Tangen J. Paradelo, et al. 2009 Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term follow-up of a randomized clinical trial J Urol 181 956 962 19167731 10.1016/j.juro.2008.11.032
29. J.F. Ward H. Zincke E.J. Bergstralh, et al. 2004 Prostate specific antigen doubling time subsequent to radical prostatectomy as a prognosticator of outcome following salvage radiotherapy J Urol 172 2244 2248 15538240 10.1097/01.ju.0000145262.34748.2b (Pubitemid 39507500)
30. F. Wenz T. Martin D. Böhmer, et al. 2010 The German S3 guideline prostate cancer: aspects for the radiation oncologist Strahlenther Oncol 186 531 534 10.1007/s00066-010-2193-3
31. T. Wiegel D. Bottke U. Steiner, et al. 2009 Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95 J Clin Oncol 27 2924 2930 19433689 10.1200/JCO.2008.18.9563
32. T. Wiegel G. Lohm D. Bottke, et al. 2009 Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome-results of a retrospective study Int J Radiat Oncol Biol Phys 73 1009 1016 18963539 10.1016/j.ijrobp.2008.06.1922